Form 4 · Filed Jul 2, 2026, 04:57 PM UTC
EBS/Emergent BioSolutions Inc.
Williams Paul Anthony — SVP, Products Business
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | S | sell | 3,000 | $8 | $25,200 | 159,098 |
Source: SEC EDGAR raw filing ↗ · Accession 0001961994-26-000024